| Symbol | ANGO |
|---|---|
| Name | ANGIODYNAMICS INC |
| Sector | HEALTH CARE |
| Region | UNDEFINED |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 14 PLAZA DRIVE, LATHAM, NY 12110 |
| Telephone | 5187981215 |
| Fax | — |
| — | |
| Website | https://www.angiodynamics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, it derives a majority of revenue from the United States. Additional info from NASDAQ: |
2026-04-23 20:59
(99% Neutral) ANGIODYNAMICS INC (ANGO) Announces Clinical Development Update
Read more
2026-04-02 11:30
(30% Negative) ANGIODYNAMICS INC (ANGO) Reports Q2 2026 Financial Results
Read more
2026-04-02 10:00
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability
Read more
2026-03-31 12:00
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference
Read more
2026-03-26 16:46
New Form SCHEDULE 13G/A - ANGIODYNAMICS INC <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000689 <b>Size:</b> 7 KB
Read more
2026-03-19 12:00
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026
Read more
2026-02-23 21:30
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
Read more
2026-02-19 13:30
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
Read more
2026-02-13 21:17
New Form SCHEDULE 13G/A - ANGIODYNAMICS INC <b>Filed:</b> 2026-02-13 <b>AccNo:</b> 0000919574-26-001036 <b>Size:</b> 23 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07472439 | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Bal… | Na | Peripheral Arterial Disease | Not_Yet_Recruiting | 2026-05-01 | 2030-05-01 | ClinicalTrials.gov |
| NCT07548164 | Comparing Two Different Boost Approaches in Radiation Therapy for People With P… | Phase3 | Prostate Cancer | Recruiting | 2026-04-16 | 2029-04-16 | ClinicalTrials.gov |
| NCT07282002 | Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegeta… | Na | Infective Endocarditis (IE) | Not_Yet_Recruiting | 2026-04-01 | 2027-03-01 | ClinicalTrials.gov |
| NCT07191548 | International Study on Treatment of Patients With Metastatic Colorectal Liver L… | Na | Colorectal Adenocarcinoma Metastatic in the Liver | Not_Yet_Recruiting | 2026-02-01 | 2029-02-01 | ClinicalTrials.gov |
| NCT07192731 | International Study on Treatment of Liver (HCC) Patients With IRE | Na | Hepatocellular Carcinoma (HCC) | Not_Yet_Recruiting | 2026-02-01 | 2029-02-01 | ClinicalTrials.gov |
| NCT06697314 | Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneo… | Na | Acute Pulmonary Embolism (PE) | Recruiting | 2025-06-15 | 2028-06-01 | ClinicalTrials.gov |
| NCT06185556 | COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic B… | Phase2 | Colorectal Cancer | Recruiting | 2024-08-20 | 2031-09-01 | ClinicalTrials.gov |
| NCT06630624 | Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IR… | Phase1 | Colorectal Cancer | Recruiting | 2024-07-10 | 2031-08-01 | ClinicalTrials.gov |
| NCT04510714 | BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation] | Na | Sarcoma | Recruiting | 2023-06-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT05318092 | Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspi… | Na | Pulmonary Embolism | Completed | 2022-10-19 | 2024-01-04 | ClinicalTrials.gov |
| NCT04972097 | Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue | Na | Prostate Cancer | Completed | 2022-03-29 | 2024-08-14 | ClinicalTrials.gov |
| NCT05284240 | Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Trea… | Na | Peripheral Arterial Disease | Completed | 2022-03-17 | 2024-09-25 | ClinicalTrials.gov |
| NCT01972867 | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | Na | Prostate Cancer | Unknown | 2021-05-13 | 2024-05-01 | ClinicalTrials.gov |
| NCT03899636 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancre… | Phase3 | Stage III Pancreatic Cancer | Active_Not_Recruiting | 2021-02-23 | 2025-04-01 | ClinicalTrials.gov |
| NCT04229563 | Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With In… | — | Infrainguinal Peripheral Artery Disease | Unknown | 2020-08-04 | 2023-04-17 | ClinicalTrials.gov |
| NCT03899649 | A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | — | Stage III Pancreatic Cancer | Active_Not_Recruiting | 2019-05-08 | 2025-04-01 | ClinicalTrials.gov |
| NCT02796300 | Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters | Na | Chronic Kidney Disease | Terminated | 2017-01-20 | 2019-06-25 | ClinicalTrials.gov |
| NCT02828709 | Safety and Feasibility of IRE for SRMs | Phase2 | Kidney Cancer | Unknown | 2016-07-01 | 2019-07-01 | ClinicalTrials.gov |
| NCT02215369 | SeCure Endovenous Laser Treatment Study | Na | Chronic Venous Insufficiency | Completed | 2015-01-01 | 2019-01-14 | ClinicalTrials.gov |
| NCT01921114 | The PROOF Study: The PICC Related Obstruction Of Flow Study | Na | Patients Indicated for a PICC for Any Medical Condition | Terminated | 2013-10-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01790451 | Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Can… | Phase1 | Prostate Cancer | Completed | 2013-08-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01064895 | Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE) | — | Acute Kidney Injury | Terminated | 2010-02-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00571987 | Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Dec… | Phase1 | Cancer of the Breast | Completed | 2004-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation | Phase2 | Non Small Cell Lung Cancer | Completed | 2001-07-01 | 2007-12-01 | ClinicalTrials.gov |
Total clinical trials: 24
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| Stereotactic Body Radiation Therapy | Drug | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| NanoKnife System | Other | Phase PHASE3 | Prostate Cancer | RECRUITING | NCT07548164 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AlphaReturn Blood Management System | Other | Approved | Pulmonary Embolism Acute | RECRUITING | NCT07280247 |
| AngioVac System | Other | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AngioVac System | DEVICE | Approved | Infective Endocarditis (IE) | NOT_YET_RECRUITING | NCT07282002 |
| AlphaReturn Blood Management System | DEVICE | Approved | Pulmonary Embolism Acute | NOT_YET_RECRUITING | NCT07280247 |
| Balloon Angioplasty | DEVICE | Approved | Peripheral Arterial Disease | NOT_YET_RECRUITING | NCT07472439 |
| Auryon Atherectomy System | DEVICE | Approved | Peripheral Arterial Disease | NOT_YET_RECRUITING | NCT07472439 |
| AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System | DEVICE | Approved | Acute Pulmonary Embolism (PE) | RECRUITING | NCT06697314 |
| IP-001 | DRUG | Phase PHASE1 | Colorectal Cancer | RECRUITING | NCT06630624 |
| Pembrolizumab | DRUG | Phase PHASE1 | Pancreatic Cancer | COMPLETED | NCT06378047 |
| Stereotactic body radiotherapy | RADIATION | Phase PHASE2 | Colorectal Cancer | RECRUITING | NCT06185556 |
| Irreversible electroporation | PROCEDURE | Phase PHASE2 | Colorectal Cancer | RECRUITING | NCT06185556 |
| AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE | DEVICE | Approved | Pulmonary Embolism | COMPLETED | NCT05318092 |
| Auryon Laser System | DEVICE | Approved | Peripheral Arterial Disease | COMPLETED | NCT05284240 |
| Image guided percutaneous microwave ablation | DEVICE | Approved | Sarcoma | RECRUITING | NCT04510714 |
| AURYON™ System | DEVICE | Preclinical | Infrainguinal Peripheral Artery Disease | UNKNOWN | NCT04229563 |
| SOC | DRUG | Preclinical | Stage III Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT03899649 |
| NanoKnife System | DEVICE | Preclinical | Stage III Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT03899649 |
| Modified FOLFIRINOX Regimen | DRUG | Phase PHASE3 | Stage III Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT03899636 |
| Standard of Care Catheter | DEVICE | Approved | Central Venous Catheter | COMPLETED | NCT03109574 |
| BioFlo DuraMax Chronic Hemodialysis Catheter | DEVICE | Approved | Central Venous Catheter | COMPLETED | NCT03109574 |
| Palindrome Dialysis Catheter | DEVICE | Approved | Chronic Kidney Disease | TERMINATED | NCT02796300 |
| Bioflo Dialysis Catheter | DEVICE | Approved | Chronic Kidney Disease | TERMINATED | NCT02796300 |
| AngioVac | DEVICE | Preclinical | Heart Disease | COMPLETED | NCT02775565 |
| VenaCure EVLT 400 µm fiber Procedure Kit | DEVICE | Approved | Chronic Venous Insufficiency | COMPLETED | NCT02215369 |
| NanoKnife Procedure | DEVICE | Approved | Prostate Cancer | UNKNOWN | NCT01972867 |
| Bard® Dual-Lumen PowerPICC SOLO2® | DEVICE | Approved | Patients Indicated for a PICC for Any Medical Condition | TERMINATED | NCT01921114 |
| BioFlo™ Peripherally Inserted Central Catheter (PICC) | DEVICE | Approved | Patients Indicated for a PICC for Any Medical Condition | TERMINATED | NCT01921114 |
| Irreversible Electroporation | DEVICE | Approved | Hepatocellular Carcinoma (HCC) | NOT_YET_RECRUITING | NCT07192731 |
| NanoKnife Low Energy Direct Current (LEDC) System Ablation | DEVICE | Phase PHASE2 | Pancreatic Adenocarcinoma | COMPLETED | NCT01369420 |
| VenaCure EVLT NeverTouch | DEVICE | Approved | Varicose Veins | WITHDRAWN | NCT01173419 |
| VNUS RF ClosureFAST | DEVICE | Approved | Varicose Veins | WITHDRAWN | NCT01173419 |
| Radiofrequency Ablation | DEVICE | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT01153035 |
| Ablation with the NanoKnife Low Energy Direct Current (LEDC) System | DEVICE | Approved | Carcinoma, Hepatocellular | COMPLETED | NCT01078415 |
| Benephit catheter for Targeted Renal Therapy | DEVICE | Preclinical | Acute Kidney Injury | TERMINATED | NCT01064895 |
| RF ablation (Rita Medical Systems Model 1500x) | DEVICE | Phase PHASE2 | Non Small Cell Lung Cancer | COMPLETED | NCT00690703 |
| AngioDynamics (previously RITA Med,Inc) radiofrequency delivery system (consisting of a generator and Starburst XL probe) | DEVICE | Phase PHASE1 | Cancer of the Breast | COMPLETED | NCT00571987 |
Total products: 69